Biomarkers for predicting postmenopausal coronary heart disease

被引：8

作者：

Spoletini, Ilaria ^{[1
]}

Vitale, Cristiana ^{[1
]}

Rosano, Giuseppe M. C. ^{[1
,2
]}

机构：

[1] IRCCS San Raffaele Pisana, Ctr Clin & Basic Res, I-00163 Rome, Italy

[2] San Raffaele Sulmona, Clin Res Ctr, Sulmona, Italy

来源：

BIOMARKERS IN MEDICINE | 2011年 / 5卷 / 04期

关键词：

atherosclerosis; biomarkers; coronary heart disease; dyslipidemia; hormone therapy; inflammation; menopause; oxidative stress; C-REACTIVE-PROTEIN; HORMONE REPLACEMENT THERAPY; SERUM URIC-ACID; ESTROGEN PLUS PROGESTIN; CARDIOVASCULAR RISK PREDICTION; METABOLIC SYNDROME; WOMENS HEALTH; INFLAMMATORY BIOMARKERS; ATHEROSCLEROSIS RISK; MULTIPLE BIOMARKERS;

D O I：

10.2217/BMM.11.51

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Coronary heart disease (CHD) is the main cause of death in post-menopausal women (PMW). Beyond the 'traditional' cardiovascular risk factors of CHD, newer biomarkers, reflecting inflammation, endothelial function and oxidative stress, have received growing consideration. We systematically reviewed the literature on the biomarkers for predicting CHD in PMW. C-reactive protein, IL-6 and Lipoprotein (a) have been consistently found to be associated with CHD risk in PMW. However, no evidence supports the existence of a causal and independent link between such biomarkers and CHD in PMW. Also, the new biomarkers only marginally improve cardiovascular risk prediction. Upcoming studies are needed to provide further evidence on the validity of the new biomarkers in PMW and to understand their relationships with hormone therapy, opening new avenues for prevention.

引用

页码：485 / 495

页数：11

共 101 条

[51]

LINDHEIM SR, 1993, FERTIL STERIL, V60, P664

[52]

Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259

[53] Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J].

Lloyd-Jones, Donald ;

Adams, Robert ;

Carnethon, Mercedes ;

De Simone, Giovanni ;

Ferguson, T. Bruce ;

Flegal, Katherine ;

Ford, Earl ;

Furie, Karen ;

Go, Alan ;

Greenlund, Kurt ;

Haase, Nancy ;

Hailpern, Susan ;

Ho, Michael ;

Howard, Virginia ;

Kissela, Brett ;

Kittner, Steven ;

Lackland, Daniel ;

Lisabeth, Lynda ;

Marelli, Ariane ;

McDermott, Mary ;

Meigs, James ;

Mozaffarian, Dariush ;

Nichol, Graham ;

O'Donnell, Christopher ;

Roger, Veronique ;

Rosamond, Wayne ;

Sacco, Ralph ;

Sorlie, Paul ;

Stafford, Randall ;

Steinberger, Julia ;

Thom, Thomas ;

Wasserthiel-Smoller, Sylvia ;

Wong, Nathan ;

Wylie-Rosett, Judith ;

Hong, Yuling .

CIRCULATION, 2009, 119 (03) :E21-E181

[54] Expression of interleukin-10 in advanced human atherosclerotic plaques -: Relation to inducible nitric oxide synthase expression and cell death [J].

Mallat, Z ;

Heymes, C ;

Ohan, J ;

Faggin, E ;

Lesèche, G ;

Tedgui, A .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :611-616

[55] 2003 European society of hypertension -: European Society of Cardiology guidelines for the management of arterial hypertension [J].

Mancia, G ;

Rosei, EA ;

Cifkova, R ;

DeBacker, G ;

Erdine, S ;

Fagard, R ;

Farsang, C ;

Heagerty, AM ;

Kawecka-Jaszcs, K ;

Kiowski, W ;

Kjeldsen, S ;

Lüscher, T ;

McInnes, G ;

Mallion, JM ;

Brien, EO ;

Poulter, NR ;

Priori, SG ;

Rahn, KH ;

Rodicio, JL ;

Ruilope, LM ;

Safar, M ;

Staessen, JA ;

van Zwieten, P ;

Waeber, B ;

Williams, B ;

Zanchetti, A ;

Zannad, F .

JOURNAL OF HYPERTENSION, 2003, 21 (06) :1011-1053

[56] Estrogen plus progestin and the risk of coronary heart disease [J].

Manson, JE ;

Hsia, J ;

Johnson, KC ;

Rossouw, JE ;

Assaf, AR ;

Lasser, NL ;

Trevisan, M ;

Black, HR ;

Heckbert, SR ;

Detrano, R ;

Strickland, OL ;

Wong, ND ;

Crouse, JR ;

Stein, E ;

Cushman, M ;

Alving, B ;

Rossouw, JE ;

Pottern, L ;

Ludlam, S ;

McGowan, JA ;

Prentice, R ;

Anderson, G ;

LaCroix, A ;

Patterson, R ;

McTiernan, A ;

Cochrane, B ;

Hunt, J ;

Tinker, L ;

Kooperberg, C ;

McIntosh, M ;

Wang, CY ;

Chen, C ;

Bowen, D ;

Kristal, A ;

Stanford, J ;

Urban, N ;

Weiss, N ;

White, E ;

Shumaker, S ;

Rautaharju, P ;

Prineas, R ;

Naughton, M ;

Stein, E ;

Laskarzewski, P ;

Cummings, S ;

Nevitt, M ;

Dockrell, M ;

Harnack, L ;

Cammarata, F ;

Lindenfelser, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :523-534

[57] Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women - A report from the Women's Ischemia Syndrome Evaluation [J].

Marroquin, OC ;

Kip, KE ;

Kelley, DE ;

Johnson, BD ;

Shaw, LJ ;

Merz, CNB ;

Sharaf, BL ;

Pepine, CJ ;

Sopko, G ;

Reis, SE .

CIRCULATION, 2004, 109 (06) :714-721

[58] Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study [J].

May, M. ;

Lawlor, D. A. ;

Brindle, P. ;

Patel, R. ;

Ebrahim, S. .

HEART, 2006, 92 (10) :1396-1401

[59] Serum uric acid and risk of coronary heart disease: Atherosclerosis risk in communities (ARIC) study [J].

Moriarity, JT ;

Folsom, AR ;

Iribarren, C ;

Nieto, FJ ;

Rosamond, WD .

ANNALS OF EPIDEMIOLOGY, 2000, 10 (03) :136-143

[60] Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women [J].

Nguyen, TT ;

Ellefson, RD ;

Hodge, DO ;

Bailey, KR ;

Kottke, TE ;

AbuLebdeh, HS .

CIRCULATION, 1997, 96 (05) :1390-1397

← 1 2 3 4 5 6 7 8 9 10 →